Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy

被引：0
|
作者：
Heidy Cedeño
Rafael Araúz
Fernando Cebamanos
Idalmis de Torraza
Ana Porcell
机构：
[1] Instituto Oncológico Nacional,Department Internal Medicine
[2] Instituto Oncológico Nacional,Department of Medical Oncology
[3] Department of Radiation Oncology Instituto Oncológico Nacional,Department of Pathology
[4] Instituto Oncológico Nacional,undefined
来源：
BMC Cancer | / 7卷 / Suppl 1期
关键词：
Trastuzumab; Axillary Lymph Node; Anthracyclines; Advanced Breast Cancer; Complete Pathological Response;
D O I：
10.1186/1471-2407-7-S1-A50
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Impact of HER2 Overexpression and Coexpression of Hormonal Receptors on Pathological Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
    Moscoso, Louis
    Ruiz-Merino, Guadalupe
    Salazar Huayna, Lourdes
    Iborra-Lacal, Emma
    Escriva de Romani, Santiago
    Jimenez-Lucas, Maria
    Siso Raber, Christian
    Cabezas-Herrera, Juan
    Peg, Vicente
    Ramon Y Cajal, Santiago
    Pinero-Madrona, Antonio
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 168 - 169
  • [42] Impact of HER2 Overexpression and Coexpression of Hormonal Receptors on Pathological Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
    Moscoso, Louis
    Ruiz-Merino, Guadalupe
    Huayna, Lourdes Salazar
    Iborra-Lacal, Emma
    de Romani, Santiago Escriva
    Jimenez-Lucas, Maria
    Raber, Christian Siso
    Cabezas-Herrera, Juan
    Peg, Vicente
    Ramon Y Cajal, Santiago
    Pinero-Madrona, Antonio
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 168 - 169
  • [43] Neoadjuvant trastuzumab in HER2-positive breast cancer, is pathological complete response enough?
    Ruvalcaba-Limon, Eva
    Pozo-Romero, Mariela
    Bautista-Pina, Veronica
    Tenorio-Torres, Alberto
    Morales-Vazquez, Flavia
    Rodriguez-Cuevas, Sergio
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 342 - 344
  • [44] Pathological complete response with neoadjuvant docetaxel, carboplatin and trastuzumab in HER2-positive, locally advanced breast cancer on behalf of the GETN(A) Group.
    Coudert, B
    Largillier, R
    Chollet, P
    Camponne, M
    Coeffic, D
    Priou, F
    Gligorov, J
    Martin, X
    Lenoir, VT
    Weber, B
    Arnould, L
    Bleuse, JP
    Vasseur, B
    Serin, D
    Namer, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S223 - S223
  • [45] Microtubule-associated protein tau is a marker of pathological complete response in Her-2/neu positive neoadjuvant treated breast cancer patients
    Rueckert, S.
    Wirtz, R. M.
    Lenhard, M. S.
    Hasmueller, S.
    Ditsch, N.
    Ruehl, I.
    Kahlert, S.
    Bauerfeind, I.
    Fasching, P. A.
    Untch, M.
    EJC SUPPLEMENTS, 2008, 6 (07): : 191 - 192
  • [46] COMPLETE RESPONSE RATE TO INDUCTION CHEMOTHERAPY IN HER2 POSITIVE INFLAMMATORY BREAST CANCER
    Kolarevic, D.
    Tomasevic, Z.
    Dekic, N. Andjelic
    Milosevic, S.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 52 - 52
  • [47] Microtubule-associated protein tau is a marker of pathological complete response in Her-2/neu positive neoadjuvant treated breast cancer patients
    Rueckert, S.
    Wirtz, R.
    Lenhard, M.
    Hasmueller, S.
    Ditsch, N.
    Ruehl, I
    Kahlert, S.
    Bauerfeind, I
    Untch, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S89 - S90
  • [48] Pathological complete response in HER2 positive breast cancer treated with trastuzumab and chemotherapy: Predictive factors report.
    Cudos, Ariadna Gasol
    Morales, Serafin
    Alvarez, Anna Novell
    Lopez, Anna Serrate
    Sanchez, Ana Velasco
    Salvia, Antonieta Salud
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Prognostic Significance of HER2 Expression Changes Following Neoadjuvant Chemotherapy in Saudi Patients With Locally Advanced Breast Cancer
    Al-Saleh, Khalid
    Aldiab, Abdurrahman
    Salah, Tareq
    Arafah, Maria
    Husain, Sufia
    Al-Rikabi, Ammar
    Abd El-Aziz, Nashwa
    CLINICAL BREAST CANCER, 2021, 21 (04) : E362 - E367
  • [50] HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    Ma, Fei
    Fan, Ying
    Luo, Yang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (03): : E187 - E192
12345